Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
$2.1M
Market Cap • 3/13/2025
2011
(14 years)
Founded
2016
(9 years ago)
IPO
NASDAQ
Listing Exchange
Cambridge
Headquarters • Massachusetts
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!